{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T03:30:06Z","timestamp":1776569406636,"version":"3.51.2"},"reference-count":53,"publisher":"Japan Atherosclerosis Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2016]]},"DOI":"10.5551\/jat.35949","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T18:09:18Z","timestamp":1467742158000},"page":"891-900","source":"Crossref","is-referenced-by-count":37,"title":["Translational Research for Improving the Care of Familial Hypercholesterolemia: The \u201cTen Countries Study\u201d and Beyond"],"prefix":"10.5551","volume":"23","author":[{"given":"Gerald F","family":"Watts","sequence":"first","affiliation":[{"name":"School of Medicine and Pharmacology, University of Western Australia"},{"name":"Lipid Disorders Clinic, Cardiometabolic Service, Department of Cardiology, Royal Perth Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip YA","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"George","sequence":"additional","affiliation":[{"name":"Biochemistry and Pathology, Canterbury Health Laboratories, Lipid Clinic, Christchurch Hospital, University of Otago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S","family":"Hagger","sequence":"additional","affiliation":[{"name":"Health Psychology and Behavioural Medicine Research Group, School of Psychology and Speech Pathology, Faculty of Health Science, Curtin university"},{"name":"Faculty of Sport and Health Sciences, University of Jyv\u00e4skyl\u00e4"},{"name":"School of Applied Psychology and Menzies Health Institute, Griffith University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Atherosclerosis, Beijing Anzhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kah Lin","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A David","family":"Marais","sequence":"additional","affiliation":[{"name":"Division of Chemical Pathology, University of Cape Town Health Science Faculty"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miida","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, Juntendo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hapizah M","family":"Nawawi","sequence":"additional","affiliation":[{"name":"Institute for Pathology, Laboratory and Forensic Medicine (I-PPerForM) and Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Pang","sequence":"additional","affiliation":[{"name":"School of Medicine and Pharmacology, University of Western Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Euy","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes B","family":"Gonzalez-Santos","sequence":"additional","affiliation":[{"name":"Section of Preventive Cardiology, Department of Cardiology, Philippine General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta-Chen","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Cardiovascular Center, National Taiwan University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh Huong","family":"Truong","sequence":"additional","affiliation":[{"name":"Hanoi Medical University and Vietnam National Heart Institute, Bach Mai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul D","family":"Santos","sequence":"additional","affiliation":[{"name":"Lipid Clinic Heart Institute (InCor), University of S\u00e3o Paulo Medical School Hospital, and Preventive Medicine Centre and Cardiology Program Hospital Israelita Albert Einstein"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handrean","family":"Soran","sequence":"additional","affiliation":[{"name":"Cardiovascular Trials Unit, The Old St Mary's Hospital, Central Manchester University Hospital NHS Foundation Trust"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Community Medicine, Graduate School of Medicine, Osaka University"},{"name":"Rinku General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, The Chinese University of Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for tha members of the \"Ten countries Study\"","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Austin MA, Hutter CM, Zimmern RL and Humphries SE: Genetic causes of monogenic heterozygous familial hypercholesterolaemia: A HuGE prevalence review. Am J Epidemiol, 2004; 160: 407-420","DOI":"10.1093\/aje\/kwh236"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Marks D, Thorogood M, Neil HAW and Humphries SE: A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis, 2003; 168: 1-14","DOI":"10.1016\/S0021-9150(02)00330-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Goldstein JL, Schrott HG, Hazzard WR, Bierman EL and Motulsky AG: Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest, 1973; 52: 1544-1568","DOI":"10.1172\/JCI107332"},{"key":"4","unstructured":"4) Goldstein JL, Hobbs HH and Brown MS: The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill Information Services Company, New York, 2001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Raal FJ and Santos RD: Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment. Atherosclerosis, 2012; 223: 262-268","DOI":"10.1016\/j.atherosclerosis.2012.02.019"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sjouke B, Kusters DM, Kindt I, Besseling J, Defesche JC, Sijbrands EJG, Roeters van Lennep JE, Stalenhoef AFH, Wiegman A, de Graaf J, Fouchier SW, Kastelein JJP and Hovingh GK: Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype\u2013phenotype relationship, and clinical outcome. Eur Heart J, 2014; ehu058","DOI":"10.1016\/S0735-1097(14)62053-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Pang J, Poulter EB, Bell DA, Bates TR, Jefferson V-L, Hillis GS, Schultz CJ and Watts GF: Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit. J Clin Lipidol, 2015; 9: 703-708","DOI":"10.1016\/j.jacl.2015.07.005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Watts GF, Juniper A, van Bockxmeer F, Ademi Z, Liew D and O'Leary P: Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations. Int J Evid Based Healthc, 2012; 10: 211-221","DOI":"10.1111\/j.1744-1609.2012.00272.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK and Livingston M: Integrated Guidance on the Care of Familial Hypercholesterolaemia from the International FH Foundation. Int J Cardiol, 2014; 171: 309-325","DOI":"10.1016\/j.ijcard.2013.11.025"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ademi Z, Watts GF, Juniper A and Liew D: A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia. Int J Cardiol, 2013; 167: 2391-2396","DOI":"10.1016\/j.ijcard.2013.01.280"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Versmissen J, Oosterveer DM, Yazdanpanah M, Defesche JC, Basart DCG, Liem AH, Heeringa J, Witteman JC, Lansberg PJ, Kastelein JJP and Sijbrands EJG: Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. Br Med J, 2008; 337: a2423","DOI":"10.1136\/bmj.a2423"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, Seed M, Humphries SE and on behalf of the Simon Broome Familial Hyperlipidaemia Register Group: Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J, 2008; 29: 2625-2633","DOI":"10.1093\/eurheartj\/ehn422"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Harada-Shiba M, Sugisawa T, Makino H, Abe M, Tsushima M, Yoshimasa Y, Yamashita T, Miyamoto Y, Yamamoto A, Tomoike H and Yokoyama S: Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia. J Atheroscler Thromb, 2010; 17: 667-674","DOI":"10.5551\/jat.4143"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Raal FJ, Pilcher GJ, Panz VR, van Deventer HE, Brice BC, Blom DJ and Marais AD: Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy. Circulation, 2011; 124: 2202-2207","DOI":"10.1161\/CIRCULATIONAHA.111.042523"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ and Defesche JC: Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease Consensus Statement of the European Atherosclerosis Society. Eur Heart J, 2013; 34: 3478-3490","DOI":"10.1093\/eurheartj\/eht273"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Arai H, Ding Y-A and Yamashita S: Impact of the Integrated Guidance on the Care of Familial Hypercholesterolaemia. J Atheroscler Thromb, 2014; 21: 366-374","DOI":"10.5551\/jat.23754"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Harada-Shiba M, Arai H, Oikawa S, Ohta T, Okada T, Okamura T, Nohara A, Bujo H, Yokote K and Wakatsuki A: Guidelines for the management of familial hypercholesterolemia. J Atheroscler Thromb, 2012; 19: 1043-1060","DOI":"10.5551\/jat.14621"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Watts GF, Sullivan DR, Poplawski N, van Bockxmeer F, Hamilton-Craig I, Clifton PM, O'Brien R, Bishop W, George P, Barter PJ, Bates T, Burnett JR, Coakley J, Davidson P, Emery J, Martin A, Farid W, Freeman L, Geelhoed E, Juniper A, Kidd A, Kostner K, Krass I, Livingston M, Maxwell S, O'Leary P, Owaimrin A, Redgrave TG, Reid N, Southwell L, Suthers G, Tonkin A, Towler S and Trent R: Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements, 2011; 12: 221-263","DOI":"10.1016\/j.atherosclerosissup.2011.06.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hu M, Hooper AJ, Bockxmeer FMv, Watts GF, Chan JC and Tomlinson B: Management of Familial Hypercholesterolemia in Hong Kong. J Atheroscler Thromb, 2016; 23: 520-531","DOI":"10.5551\/jat.34314"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Lee SH: Characteristics and Vascular Complications of Familial Hypercholesterolemia in Korea. J Atheroscler Thromb, 2016; 23: 532-538","DOI":"10.5551\/jat.34363"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Vallejo-Vaz AJ, Kondapally Seshasai SR, Cole D, Hovingh GK, Kastelein JJP, Mata P, Raal FJ, Santos RD, Soran H, Watts GF, Abifadel M, Aguilar-Salinas CA, Akram A, Alnouri F, Alonso R, Al-Rasadi K, Banach M, Bogsrud MP, Bourbon M, Bruckert E, Car J, Corral P, Descamps O, Dieplinger H, Durst R, Freiberger T, Gaspar IM, Genest J, Harada-Shiba M, Jiang L, Kayikcioglu M, Lam CSP, Latkovskis G, Laufs U, Liberopoulos E, Nilsson L, Nordestgaard BG, O'Donoghue JM, Sahebkar A, Schunkert H, Shehab A, Stoll M, Su T-C, Susekov A, Wid\u00e9n E, Catapano AL and Ray KK: Familial hypercholesterolaemia: A global call to arms. Atherosclerosis, 2015; 243: 257-259","DOI":"10.1016\/j.atherosclerosis.2015.09.021"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22) Gidding SS, Champagne MA, de Ferranti SD, Defesche J, Ito MK, Knowles JW, McCrindle B, Raal F, Rader D, Santos RD, Lopes-Virella M, Watts GF and Wierzbicki AS: The Agenda for Familial Hypercholesterolemia - A Scientific Statement From the American Heart Association. Circulation, 2015; 132: DOI: 10.1161\/CIR.0000000000000297","DOI":"10.1161\/CIR.0000000000000297"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Soutar AK and Naoumova RP: Mechanisms of Disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med, 2007; 4: 214-225","DOI":"10.1038\/ncpcardio0836"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Hooper AJ, Nguyen LT, Burnett JR, Bates TR, Bell DA, Redgrave TG, Watts GF and van Bockxmeer FM: Genetic analysis of familial hypercholesterolaemia in Western Australia. Atherosclerosis, 2012; 224: 430-434","DOI":"10.1016\/j.atherosclerosis.2012.07.030"},{"key":"25","unstructured":"25) Khera AV, Won H-H, Peloso GM, Lawson KS, Bartz TM, Deng X, van Leeuwen EM, Natarajan P, Emdin CA, Bick AG, Morrison AC, Brody JA, Gupta N, Nomura A, Kessler T, Duga S, Bis JC, van Duijn CM, Cupples LA, Psaty B, Rader DJ, Danesh J, Schunkert H, McPherson R, Farrall M, Watkins H, Lander E, Wilson JG, Correa A, Boerwinkle E, Merlini PA, Ardissino D, Saleheen D, Gabriel S and Kathiresan S: Diagnostic Yield of Sequencing Familial Hypercholesterolemia Genes in Patients with Severe Hypercholesterolemia. J Am Coll Cardiol, 2016; 10.1016\/ j.jacc.2016.1003.1520"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, Daniels SR, Gidding SS, de Ferranti SD, Ito MK, McGowan MP, Moriarty PM, Cromwell WC, Ross JL and Ziajka PE: Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol, 2011; 5: 133-140","DOI":"10.1016\/j.jacl.2011.03.001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Shin DG, Han SM, Kim DI, Rhee M-Y, Lee B-K, Ahn YK, Cho BR, Woo J-T, Hur S-H, Jeong J-O, Jang Y, Lee JH and Lee S-H: Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease \u2013 A study supported by the Korean Society of Lipidology and Atherosclerosis. Atherosclerosis, 2015; 243: 53-58","DOI":"10.1016\/j.atherosclerosis.2015.08.033"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Haralambos K, Whatley SD, Edwards R, Gingell R, Townsend D, Ashfield-Watt P, Lansberg P, Datta DBN and McDowell IFW: Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales. Atherosclerosis, 2015; 240: 190-196","DOI":"10.1016\/j.atherosclerosis.2015.03.003"},{"key":"29","unstructured":"29) Muir LA, George PM, Laurie AD, Reid N and Whitehead L: Preventing cardiovascular disease: a review of the effectiveness of identifying the people with familial hypercholesterolaemia in New Zealand. N Z Med J, 2010; 123: 97-102"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Laurie AD, Scott RS and George PM: Genetic screening of patients with familial hypercholesterolaemia (FH): a New Zealand perspective. Atherosclerosis Supplements, 2004; 5: 13-15","DOI":"10.1016\/j.atherosclerosissup.2004.09.001"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Goldberg AC and Gidding SS: Knowing the Prevalence of Familial Hypercholesterolemia Matters. Circulation, 2016; 133: 1054-1057","DOI":"10.1161\/CIRCULATIONAHA.116.021673"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Shi Z, Yuan B, Zhao D, Taylor AW, Lin J and Watts GF: Familial hypercholesterolemia in China: Prevalence and evidence of underdetection and undertreatment in a community population. Int J Cardiol, 2014; 174: 834-836","DOI":"10.1016\/j.ijcard.2014.04.165"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Watts GF, Shaw JE, Pang J, Magliano DJ, Jennings GLR and Carrington MJ: Prevalence and treatment of familial hypercholesterolemia in Australian communities. Int J Cardiol, 2015; 185: 69-71","DOI":"10.1016\/j.ijcard.2015.03.027"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) de Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK and Sheldrick RC: Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation, 2016; 133: 1067-1072","DOI":"10.1161\/CIRCULATIONAHA.115.018791"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Benn M, Watts GF, Tybj\u00e6rg-Hansen A and Nordestgaard BG: Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. Eur Heart J, 2016; 10.1093\/eurheartj\/ehw1028","DOI":"10.1093\/eurheartj\/ehw028"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Benn M, Watts GF, Tybjaerg-Hansen A and Nordestgaard BG: Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication. J Clin Endocrinol Metab, 2012; 97: 3956-3964","DOI":"10.1210\/jc.2012-1563"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Pang J, Martin AC, Mori TA, Beilin LJ and Watts GF: Prevalence of familial hypercholesterolaemia in adolescents: potential value of universal screening? The Journal of Pediatrics, 2016; 170: 315-316","DOI":"10.1016\/j.jpeds.2015.11.019"},{"key":"38","unstructured":"39) Kirke A, Watts GF and Emery J: Detecting familial hypercholesterolaemia in general practice. Aust Fam Physician, 2012; 41: 965-968"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40) Qureshi N, Humphries SE, Seed M, Rowlands P, Minhas R and NICE Guideline Development Group: Identification and management of familial hypercholesterolaemia: what does it mean to primary care? Br J Gen Pract, 2009; 59: 773-778","DOI":"10.3399\/bjgp09X472674"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41) Bell DA, Garton-Smith J, Vickery A, Kirke A, Pang J, Bates TR and Watts GF: Familial Hypercholesterolaemia in Primary Care: Knowledge and Practices Among General Practitioners in Western Australia. Heart, Lung and Circulation, 2014; 23: 309-313","DOI":"10.1016\/j.hlc.2013.08.005"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42) Pang J, Sullivan DR, Harada-Shiba M, Ding PY, Selvey S, Ali S and Watts GF: Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: A pilot study. J Clin Lipidol, 2015; 9: 42-48","DOI":"10.1016\/j.jacl.2014.09.011"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43) Datta BN, McDowell IF and Rees A: Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia. Curr Opin Lipidol, 2010; 21: 366-371","DOI":"10.1097\/MOL.0b013e32833c14e2"},{"key":"43","unstructured":"44) National Institute for Health and Clinical Excellence and The National Collaborating Centre for Primary Care: NICE Clinical Guideline 71: Identification and management of familial hypercholesterolaemia. 2008;"},{"key":"44","unstructured":"45) Pedersen KMV, Humphries SE, Roughton M and Besford JS: The National Audit of the Management of Familial Hypercholesterolaemia 2010: Full report. 2010;"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46) Claassen L, Henneman L, Kindt I, Marteau TM and Timmermans DRM: Perceived Risk and Representations of Cardiovascular Disease and Preventive Behaviour in People Diagnosed with Familial Hypercholesterolemia. J Health Psychol, 2010; 15: 33-43","DOI":"10.1177\/1359105309345170"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47) Hollman G, Olsson AG and Ek A-C: Disease knowledge and adherence to treatment in patients with familial hypercholesterolemia. J Cardiovasc Nurs, 2006; 21: 103-108","DOI":"10.1097\/00005082-200603000-00005"},{"key":"47","doi-asserted-by":"crossref","unstructured":"48) Weiner K and Durrington PN: Patients' understandings and experiences of familial hypercholesterolemia. Public Health Genomics, 2008; 11: 273-282","DOI":"10.1159\/000121398"},{"key":"48","doi-asserted-by":"crossref","unstructured":"49) Muir LA, George PM and Whitehead L: Using the experiences of people with familial hypercholesterolaemia to help reduce the risk of cardiovascular disease: a qualitative systematic review. J Adv Nurs, 2012; 68: 1920-1932","DOI":"10.1111\/j.1365-2648.2012.05957.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"50) Hardcastle SJ, Legge E, Laundy CS, Egan SJ, French R, Watts GF and Hagger MS: Patients' Perceptions and Experiences of Familial Hypercholesterolemia, Cascade Genetic Screening and Treatment. International Journal of Behavioral Medicine, 2015; 22: 92-100","DOI":"10.1007\/s12529-014-9402-x"},{"key":"50","doi-asserted-by":"crossref","unstructured":"51) Hagger MS, Hardcastle SJ, Hingley C, Strickland E, Pang J and Watts GF: Predicting Self-Management Behaviors in Familial Hypercholesterolemia Using an Integrated Theoretical Model: the Impact of Beliefs About Illnesses and Beliefs About Behaviors. International Journal of Behavioral Medicine, 2016; 23: 282-294","DOI":"10.1007\/s12529-015-9531-x"},{"key":"51","doi-asserted-by":"crossref","unstructured":"52) Ramaswami U, Cooper J and Humphries SE: The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data. Arch Dis Child, 2016; 10.1136\/archdischild-2015-308570","DOI":"10.1136\/archdischild-2015-308570"},{"key":"52","unstructured":"53) Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe. 2015; http:\/\/ screenprofh.com\/"},{"key":"53","doi-asserted-by":"crossref","unstructured":"54) Pang J, Lansberg PJ and Watts GF: International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next? J Atheroscler Thromb, 2016; 23: 505-519","DOI":"10.5551\/jat.34108"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/23\/8\/23_35949\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T15:10:52Z","timestamp":1568128252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/23\/8\/23_35949\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.35949","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}